US equities
|
MU
$1,035.84
▼-4.79%
NVDA
$230.48
▼-2.94%
SNDK
$1,609.46
▼-4.90%
AMD
$620.68
▼-3.90%
INTC
$107.08
▼-5.34%
AAPL
$340.42
▲+1.11%
META
$720.89
▼-0.06%
SPCX
$160.57
▼-4.19%
MU
$1,035.84
▼-4.79%
NVDA
$230.48
▼-2.94%
SNDK
$1,609.46
▼-4.90%
AMD
$620.68
▼-3.90%
INTC
$107.08
▼-5.34%
AAPL
$340.42
▲+1.11%
META
$720.89
▼-0.06%
SPCX
$160.57
▼-4.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Lophos Pharma
Recent news which mentions Lophos Pharma
Experts Discuss Botanical Psilocybin's Effect On Neurogenesis And More At Benzinga Cannabis Conference
April 29, 2024
Tickers
CCC
NEWS
Tags
News
t Capsoil Technologies
Lophos Pharma
From
Benzinga
Meet The Company Developing Innovative Peyote-Based Treatments For Addiction, Anxiety, And Depression
April 29, 2022
Tags
Benzinga Psychedelic Capital Conference
Lophos Pharma
Benzinga
From
Benzinga
G2 Buys Peyote-Focused Psychedelics Company Lophos Pharma
January 24, 2022
Tags
Greenridez 2/0 Acquisitions Corp
Claire Stawnyczy
Canalytica Corp
From
Benzinga